Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (2e,4e,6e,8e,10e,12e,14e)-2,6,11,15-tetramethyl-2,4,6,8,10,12,14-hexadecaheptaenedioic Acid
2. Crocetin
3. Crocetin Sodium Salt
4. Trans-sodium Crocetinate
5. Transcrocetinate Sodium
6. Tsc
7. Tsc Cpd
1. 591230-99-8
2. Transcrocetinate Sodium
3. Disodium Trans-crocetinate
4. Transcrocetinate Disodium
5. Trans-sodium Crocetinate
6. Trans-crocetin Sodium
7. Transcrocetinate Sodium [usan]
8. Yp57637wmx
9. 591230-99-8 (sodium 1
10. Disodium (all-e)-2,6,11,15-tetramethylhexadecahepta-2,4,6,8,10,12,14-enedioate
11. 64603-92-5
12. 2,4,6,8,10,12,14-hexadecaheptaenedioic Acid, 2,6,11,15-tetramethyl-, Sodium Salt (1:2), (2e,4e,6e,8e,10e,12e,14e)-
13. Sodium (2e,4e,6e,8e,10e,12e,14e)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate
14. Unii-yp57637wmx
15. Crocetin Sodium
16. Chembl3137335
17. Akos037515031
18. Transcrocetinate Sodium [who-dd]
19. E80767
20. Q27294636
21. Transcrocetinate Disodium (disodium Trans-crocetinate)
22. Disodium;(2e,4e,6e,8e,10e,12e,14e)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate
| Molecular Weight | 372.4 g/mol |
|---|---|
| Molecular Formula | C20H22Na2O4 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 6 |
| Exact Mass | 372.13134774 g/mol |
| Monoisotopic Mass | 372.13134774 g/mol |
| Topological Polar Surface Area | 80.3 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 597 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 7 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Anticarcinogenic Agents
Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. (See all compounds classified as Anticarcinogenic Agents.)
Antioxidants
Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)
ABOUT THIS PAGE
A Trans Sodium Crocetinate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trans Sodium Crocetinate, including repackagers and relabelers. The FDA regulates Trans Sodium Crocetinate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trans Sodium Crocetinate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Trans Sodium Crocetinate supplier is an individual or a company that provides Trans Sodium Crocetinate active pharmaceutical ingredient (API) or Trans Sodium Crocetinate finished formulations upon request. The Trans Sodium Crocetinate suppliers may include Trans Sodium Crocetinate API manufacturers, exporters, distributors and traders.
Trans Sodium Crocetinate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Trans Sodium Crocetinate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Trans Sodium Crocetinate GMP manufacturer or Trans Sodium Crocetinate GMP API supplier for your needs.
A Trans Sodium Crocetinate CoA (Certificate of Analysis) is a formal document that attests to Trans Sodium Crocetinate's compliance with Trans Sodium Crocetinate specifications and serves as a tool for batch-level quality control.
Trans Sodium Crocetinate CoA mostly includes findings from lab analyses of a specific batch. For each Trans Sodium Crocetinate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Trans Sodium Crocetinate may be tested according to a variety of international standards, such as European Pharmacopoeia (Trans Sodium Crocetinate EP), Trans Sodium Crocetinate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Trans Sodium Crocetinate USP).
LOOKING FOR A SUPPLIER?
